{"id":"buramate","rwe":[],"tags":[{"label":"buramate","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"buramat","offLabel":[],"synonyms":["buramate","2-hydroxyethyl benzylcarbamate","buramat","glycol benzylcarbamate","hyamate"],"timeline":[],"brandName":"Buramat","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"buramate","explanation":"Imagine your body's cells have locks on them, and the key to unlocking the right response is a specific molecule. Buramate is designed to fit into these locks, allowing the cell to respond in a way that treats a particular condition. This is a simplified explanation of how buramate works at a molecular level.","oneSentence":"Buramate works by interacting with a specific molecular target to produce a therapeutic effect.","technicalDetail":"Buramate is a small molecule that binds to a specific protein target, modulating its activity and producing a therapeutic effect through a complex interplay of biochemical pathways."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3049","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=BURAMATE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T09:04:58.711332","biosimilars":[],"competitors":[],"genericName":"buramate","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"Q9HDA6U6V4","CHEBI":"CHEBI:134851","INN_ID":"1771","UMLSCUI":"C5420998","ChEMBL_ID":"CHEMBL2103933","KEGG_DRUG":"D02639","PUBCHEM_CID":"20787"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Buramate (BURAMATE) is a small molecule drug in the buramate class, but specific details about its development, approval status, and indications are not available. As a pharma professional, further research is necessary to understand its target, mechanism of action, and commercial status. The drug's half-life, bioavailability, and generic manufacturers are also unknown. Buramate's safety considerations and potential side effects cannot be determined without more information. Further investigation is required to determine its current status and potential applications.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}